• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Product Classification

  • Print
  • Share
  • E-mail
New Search Back To Search Results
Device procalcitonin assay
Definition To aid in decision making on antibiotic therapy, including antibiotic initiation and discontinuation, for inpatients or patients in the emergency department, with suspected or confirmed lower respiratory tract infections (lrti) defined as community-acquired pneumonia (cap), acute bronchitis, and acute exacerbation of chronic obstructive pulmonary disease (aecopd).
Physical State In vitro diagnostic device
Technical Method Immunoassay, ELISA
Target Area Human serum and EDTA or heparin plasma specimens.
Regulation Medical Specialty Microbiology
Review Panel Microbiology
Product CodePRI
Premarket Review Office of In Vitro Diagnostics and Radiological Health (OIR)
Submission Type 510(k)
Regulation Number 866.3215
Device Class 2
Total Product Life Cycle (TPLC) TPLC Product Code Report
GMP Exempt? No
Implanted Device? No
Life-Sustain/Support Device? No
Third Party Review Not Third Party Eligible